Literature DB >> 19227792

"Couldn't live without it": diabetes, the costs of innovation and the price of insulin in Canada, 1922-1984.

Christopher J Rutty1.   

Abstract

This article traces insulin prices in Canada from 1922, just after its discovery at the University of Toronto, to 1984 when production fell out of Canadian control. Connaught Laboratories (part of the University of Toronto from 1914 to 1972) was the first to manufacture insulin and remained the sole Canadian producer. As a public trust, Connaught remained committed to providing insulin at the lowest possible price despite increasing economic pressures. This article analyzes the context surrounding the price of insulin preparations and how they fell from 1922 to 1942, remained unchanged until 1967, and rose during the 1970s.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19227792     DOI: 10.3138/cbmh.25.2.407

Source DB:  PubMed          Journal:  Can Bull Med Hist        ISSN: 0823-2105


  3 in total

Review 1.  100 years on: the impact of the discovery of insulin on clinical outcomes.

Authors:  John B Buse; Melanie J Davies; Brian M Frier; Athena Philis-Tsimikas
Journal:  BMJ Open Diabetes Res Care       Date:  2021-08

Review 2.  The discovery of insulin revisited: lessons for the modern era.

Authors:  Gary F Lewis; Patricia L Brubaker
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

3.  The insulin market reaches 100.

Authors:  David Beran; Edwin A M Gale; John S Yudkin
Journal:  Diabetologia       Date:  2022-03-11       Impact factor: 10.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.